Quick Search 
Drugs of the Future
Register or sign in

Volume 42, Issue 5, May 2017, Pages 265-317
Hedgehog signaling inhibitor, Treatment of myelodysplastic syndrome, Treatment of chronic myelomonocytic leukemia, Treatment of acute myeloid leukemia, Treatment of myelofibrosis.
Gras, J.
Drugs Fut 2017, 42(5): 265
Summary | Full Text: PDF 
 Larotrectinib sulfate.
Tropomyosin-related kinase (Trk) inhibitor, Treatment of solid tumors.
Gajdosik, Z.
Drugs Fut 2017, 42(5): 275
Summary | Full Text: PDF 
 Repurposing nilvadipine for treatment of dementia: an overview.
McCarthy, H., Kennelly, S., Crawford, F., Mullan, M., Cregg, F., Lawlor, B.A.
Drugs Fut 2017, 42(5): 281
Summary | Full Text: PDF 
 Therapeutic targets for Zika virus infection.
Sorbera, L., Stringer, M.
Drugs Fut 2017, 42(5): 285
Summary | Full Text: PDF 
 Pipeline on the move.
Torramade, E., Gonzalez-Brao, M., Mila, M.
Drugs Fut 2017, 42(5): 293
Full Text: PDF 
 Cambridge Healthcare Institute's Second Annual Immuno-Oncology Summit Europe.
Jago, C.
Drugs Fut 2017, 42(5): 305
Summary | Full Text: PDF 
 ENDO 2017 - 99th Annual Meeting and Exposition of the Endocrine Society. Orlando, Florida, USA - April 1-4, 2017.
Mila, M.
Drugs Fut 2017, 42(5): 313
Summary | Full Text: PDF 

© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences